179 related articles for article (PubMed ID: 35024179)
21. ROS-responsive capsules engineered from green tea polyphenol-metal networks for anticancer drug delivery.
Wang X; Li X; Liang X; Liang J; Zhang C; Yang J; Wang C; Kong D; Sun H
J Mater Chem B; 2018 Feb; 6(7):1000-1010. PubMed ID: 32254287
[TBL] [Abstract][Full Text] [Related]
22. The ameliorative effect of rosmarinic acid and epigallocatechin gallate against doxorubicin-induced genotoxicity.
Helvacioglu S; Charehsaz M; Bankoglu EE; Stopper H; Aydin A
Drug Chem Toxicol; 2024 Mar; ():1-13. PubMed ID: 38529831
[TBL] [Abstract][Full Text] [Related]
23. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
[TBL] [Abstract][Full Text] [Related]
24. Engineering a pH/Glutathione-Responsive Tea Polyphenol Nanodevice as an Apoptosis/Ferroptosis-Inducing Agent.
Mu M; Wang Y; Zhao S; Li X; Fan R; Mei L; Wu M; Zou B; Zhao N; Han B; Guo G
ACS Appl Bio Mater; 2020 Jul; 3(7):4128-4138. PubMed ID: 35025415
[TBL] [Abstract][Full Text] [Related]
25. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate.
McLaughlin N; Annabi B; Bouzeghrane M; Temme A; Bahary JP; Moumdjian R; Béliveau R
Brain Res; 2006 Feb; 1071(1):1-9. PubMed ID: 16412397
[TBL] [Abstract][Full Text] [Related]
26. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.
Sadzuka Y; Sugiyama T; Sonobe T
Toxicol Lett; 2000 Apr; 114(1-3):155-62. PubMed ID: 10713480
[TBL] [Abstract][Full Text] [Related]
27. Low dose epigallocatechin-3-gallate revives doxorubicin responsiveness by a redox-sensitive pathway in A549 lung adenocarcinoma cells.
Datta S; Sinha D
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22999. PubMed ID: 35218280
[TBL] [Abstract][Full Text] [Related]
28. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling.
Singh T; Katiyar SK
Toxicol Appl Pharmacol; 2013 Dec; 273(2):418-24. PubMed ID: 24096034
[TBL] [Abstract][Full Text] [Related]
29. A Metal-Polyphenol-Based Oxygen Economizer and Fenton Reaction Amplifier for Self-Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy.
Shi H; Wang R; Cao HC; Guo HY; Pan P; Xiong CF; Zhang LJ; Yang Q; Wei S; Liu T
Adv Healthc Mater; 2023 Jul; 12(18):e2300054. PubMed ID: 36977362
[TBL] [Abstract][Full Text] [Related]
30. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
31. Thiol-Mediated Synthesis of Hyaluronic Acid-Epigallocatechin-3-O-Gallate Conjugates for the Formation of Injectable Hydrogels with Free Radical Scavenging Property and Degradation Resistance.
Liu C; Bae KH; Yamashita A; Chung JE; Kurisawa M
Biomacromolecules; 2017 Oct; 18(10):3143-3155. PubMed ID: 28806066
[TBL] [Abstract][Full Text] [Related]
32. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
33. Boosting Doxorubicin-Induced Mitochondria Apoptosis for the Monodrug-Mediated Combination of Chemotherapy and Chemodynamic Therapy.
Liu T; Xiong CF; Zhang LJ; Jiao GH; Shi H; Feng J; Zhang XZ
Adv Healthc Mater; 2023 Jan; 12(3):e2202045. PubMed ID: 36239177
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
35. In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft.
Zhang Q; Wei D; Liu J
Cancer Lett; 2004 May; 208(2):179-86. PubMed ID: 15142676
[TBL] [Abstract][Full Text] [Related]
36. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
37. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
38. Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of
Sharma A; Vaghasiya K; Ray E; Gupta P; Gupta UD; Singh AK; Verma RK
ACS Biomater Sci Eng; 2020 Jul; 6(7):4126-4140. PubMed ID: 33463343
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Satonaka H; Ishida K; Takai M; Koide R; Shigemasa R; Ueyama J; Ishikawa T; Hayashi K; Goto H; Wakusawa S
Anticancer Res; 2017 Nov; 37(11):6071-6077. PubMed ID: 29061787
[TBL] [Abstract][Full Text] [Related]
40. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
